GlassScriptPhysician profile
Jaclyn M Ferro
NPI 1053702050
$3,785.23
in general payments reported to CMS, 2019-2025
23 companies · $64.72 in 2025
The $64.72 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $315 · 2020: $160 · 2021: $133 · 2022: $689 · 2023: $2,211 · 2024: $212 · 2025: $64.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,000 · Food and Beverage: $488.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,000.00 |
| Food and Beverage | $487.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $2,000.00 | 2023 | Slynd |
| Abbvie INC. | $380.77 | 2019-2024 | |
| Allergan, INC. | $346.90 | 2019-2022 | |
| Gynesonics, INC. | $181.24 | 2022 | |
| Coopersurgical, INC. | $164.73 | 2022-2025 | Paragard T 380a, Paragard T 380a |
| Hologic Sales and Service, LLC | $118.11 | 2019-2025 | Myosure Tissue Removal Device |
| Mayne Pharma Commercial LLC | $106.50 | 2022-2023 | |
| Ge Healthcare | $70.37 | 2024 | |
| Myovant Sciences INC. | $61.85 | 2022 | |
| Pfizer INC. | $48.93 | 2024-2025 | |
| Astellas Pharma US INC | $45.91 | 2024 | Veozah |
| Therapeuticsmd, INC. | $42.11 | 2020-2022 | |
| Evofem Biosciences, INC. | $42.10 | 2020-2024 | |
| Sobi, INC | $23.30 | 2021 | |
| Scynexis, INC. | $22.24 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $21.68 | 2023 | Tirosint, Licart |
| Bayer Healthcare Pharmaceuticals INC. | $20.91 | 2019 | |
| Galderma Laboratories, L.P. | $19.96 | 2023 | |
| Vertical Pharmaceuticals, LLC | $18.71 | 2019 | |
| Olympus America INC. | $17.96 | 2019 | |
| Dysis Medical, INC. | $12.82 | 2020 | |
| Merck Sharp & Dohme LLC | $11.07 | 2019 | |
| Organon LLC | $7.06 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaclyn Ferro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.